Cimzia – Certolizumab pegol uses, dose and side effects
Cimzia contains the active substance certolizumab pegol, which is part of a human antibody. Antibodies are proteins that specifically recognize and bind to other proteins. Cimzia binds to a specific protein called tumor necrosis factor α (TNFα) and this reduces inflammation in diseases such as rheumatoid arthritis, axial spondylitis, psoriatic arthritis, and psoriasis. Drugs that bind to TNFα are also called TNFinhibitors.
Read More